Publications
- Trial watch: chemotherapy-induced immunogenic cell death in oncology2023 | Second Faculty of Medicine
- Methods to assess DC-dependent priming of T cell responses by dying cells2020 | Second Faculty of Medicine
- Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?2019 | Second Faculty of Medicine
- Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?2019 | Second Faculty of Medicine
- Induction of tolerance and immunity by dendritic cells: Mechanisms and clinical applications2019 | Second Faculty of Medicine
- Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (toIDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice2018 | Second Faculty of Medicine
- High hydrostatic pressure in cancer immunotherapy and biomedicine2018 | Second Faculty of Medicine
- Tolerogenic Dendritic Cells from Poorly Compensated Type 1 Diabetes Patients Have Decreased Ability To Induce Stable Antigen-Specific T Cell Hyporesponsiveness and Generation of Suppressive Regulatory T Cells2017 | Second Faculty of Medicine
- NF-kappa B, p38 MAPK, ERK1/2, mTOR, STAT3 and increased glycolysis regulate stability of paricalcitol/dexamethasone-generated tolerogenic dendritic cells in the inflammatory environment2015 | Second Faculty of Medicine
- Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents2022 | Second Faculty of Medicine, First Faculty of Medicine, Third Faculty of Medicine
Loading network view...